Ken Fisher Dexcom Inc Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Dexcom Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 773,874 shares of DXCM stock, worth $51.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

773,874

Previous 780,765 0.88%

Holding current value

$51.1 Million

Previous $108 Million 18.98%

% of portfolio

0.04%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $760,146 - $967,840	-6,891 Reduced 0.88%	773,874 $87.7 Million
Q1 2024 May 09, 2024	SELL	$114.22 - $140.1 $24 Million - $29.4 Million	-209,780 Reduced 21.18%	780,765 $108 Million
Q4 2023 Mar 05, 2024	SELL	$75.49 - $124.16 $73,527 - $120,931	-974 Reduced 0.1%	990,545 $123 Million
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $1.52 Million - $2.5 Million	-20,103 Reduced 1.99%	991,519 $123 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $22.5 Million - $36 Million	-260,967 Reduced 20.51%	1,011,622 $94.4 Million
Q2 2023 Dec 12, 2023	BUY	$112.47 - $130.98 $29.3 Million - $34.1 Million	260,288 Added 25.73%	1,271,910 $163 Million
Q2 2023 Aug 08, 2023	SELL	$112.47 - $130.98 $6.11 Million - $7.11 Million	-54,313 Reduced 4.09%	1,272,589 $164 Million
Q1 2023 Dec 12, 2023	BUY	$104.0 - $122.92 $31.7 Million - $37.4 Million	304,421 Added 30.09%	1,316,043 $153 Million
Q1 2023 May 01, 2023	SELL	$104.0 - $122.92 $5.49 Million - $6.49 Million	-52,766 Reduced 3.82%	1,326,902 $154 Million
Q4 2022 Feb 03, 2023	SELL	$84.98 - $122.67 $4.56 Million - $6.58 Million	-53,672 Reduced 3.74%	1,379,668 $156 Million
Q3 2022 Nov 08, 2022	BUY	$76.35 - $94.18 $82 Million - $101 Million	1,074,492 Added 299.43%	1,433,340 $115 Million
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $18 Million - $35.2 Million	264,944 Added 282.14%	358,848 $26.7 Million
Q1 2022 May 05, 2022	BUY	$94.08 - $130.2 $757,061 - $1.05 Million	8,047 Added 9.37%	93,904 $48 Million
Q4 2021 Feb 02, 2022	BUY	$129.87 - $162.82 $4.13 Million - $5.17 Million	31,774 Added 58.75%	85,857 $46.1 Million
Q3 2021 Oct 26, 2021	SELL	$106.71 - $143.18 $13,125 - $17,611	-123 Reduced 0.23%	54,083 $29.6 Million
Q2 2021 Jul 27, 2021	BUY	$80.99 - $107.93 $327,685 - $436,684	4,046 Added 8.07%	54,206 $23.1 Million
Q1 2021 Apr 27, 2021	BUY	$84.79 - $104.74 $105,817 - $130,715	1,248 Added 2.55%	50,160 $18 Million
Q4 2020 Jan 29, 2021	BUY	$78.0 - $104.5 $2.11 Million - $2.83 Million	27,034 Added 123.57%	48,912 $18.1 Million
Q3 2020 Nov 10, 2020	BUY	$95.51 - $112.95 $30,945 - $36,595	324 Added 1.5%	21,878 $9.02 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $1.35 Million - $2.27 Million	21,554 New	21,554 $8.74 Million

Others Institutions Holding DXCM

# of Institutions

1,113

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account